Merck & Co., Inc. (MRK)

Last Price: 79.57 (2020-07-06)

Company Description

Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $46.84B
Net Income (Most Recent Fiscal Year) $9.84B
PE Ratio (Current Year Earnings Estimate) 14.86
PE Ratio (Trailing 12 Months) 14.40
PEG Ratio (Long Term Growth Estimate) 2.20
Price to Sales Ratio (Trailing 12 Months) 4.14
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 7.60
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 11.77
Pre-Tax Margin (Trailing 12 Months) 25.45%
Net Margin (Trailing 12 Months) 21.10%
Return on Equity (Trailing 12 Months) 52.46%
Return on Assets (Trailing 12 Months) 16.67%
Current Ratio (Most Recent Fiscal Quarter) 1.11
Quick Ratio (Most Recent Fiscal Quarter) 0.87
Debt to Common Equity (Most Recent Fiscal Quarter) 0.82
Inventory Turnover (Trailing 12 Months) 2.44
Book Value per Share (Most Recent Fiscal Quarter) $10.21
Earnings per Share (Most Recent Fiscal Quarter) $1.50
Earnings per Share (Most Recent Fiscal Year) $5.19
Diluted Earnings per Share (Trailing 12 Months) $3.95
Stock
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers - General
Common Shares Outstanding 2.52B
Free Float 2.52B
Market Capitalization $198.85B
Average Volume (Last 20 Days) 10.43M
Beta (Past 60 Months) 0.48
Percentage Held By Insiders (Latest Annual Proxy Report) 0.28%
Percentage Held By Institutions (Latest 13F Reports) 74.33%
Annual Dividend (Based on Last Quarter) $2.44
Dividend Yield (Based on Last Quarter) 3.10%